Correction of metabolic acidosis in continuous ambulatory peritoneal dialysis patients with borderline dialysis adequacy - effect on nutritional status, systemic inflammatory response and patient morbidity
| ISRCTN | ISRCTN35726272 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN35726272 |
| Protocol serial number | 931010 |
| Sponsor | Hong Kong Health Services Research Fund (Hong Kong) |
| Funder | Hong Kong Health Services Research Fund (Hong Kong) |
- Submission date
- 10/10/2002
- Registration date
- 10/10/2002
- Last edited
- 02/07/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr CC Szeto
Scientific
Scientific
Department of Medicine & Therapeutics
Prince of Wales Hospital
Chinese University of Hong Kong
-
-
Hong Kong
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | Evaluate the effects of correcting acidosis by oral sodium bicarbonate in peritoneal dialysis patients with weekly Kt/V values below 2.1. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Metabolic acidosis |
| Intervention | Patients will be randomised to receive either: 1. Oral sodium bicarbonate 0.9 g three times a day (tds) 2. Placebo Patients were followed up for 12 months. |
| Intervention type | Drug |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Sodium bicarbonate |
| Primary outcome measure(s) |
1. Nutritional status |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/04/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 60 |
| Key inclusion criteria | 1. End-stage renal failure patients 2. Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD) 3. Weekly Kt/V 1.6 to 1.9 4. Metabolic acidosis (plasma bicarbonate less than 24 mmol/l) |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 01/12/2000 |
| Date of final enrolment | 01/04/2003 |
Locations
Countries of recruitment
- Hong Kong
Study participating centre
Department of Medicine & Therapeutics
-
-
Hong Kong
-
Hong Kong
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/08/2003 | Yes | No |